FDA Ask 5 Drug Makers To Recall Certain Metformin Pills Due To NDMA Contamination
SILVER SPRING, Md. — The Food and Drug Administration on May 28 alerted patients and health care professionals that laboratory tests revealed unacceptably high levels of N-nitrosodimethylamine (NDMA) in extended release...To view the full article, register now.
Already a subscriber? Click here to view full article